Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-07-18
2006-07-18
Guzo, David (Department: 1636)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000, C435S252100, C435S254800, C530S402000, C530S350000
Reexamination Certificate
active
07078508
ABSTRACT:
Ixolaris, a novel protein with anticoagulant activity is described. Ixolaris can be isolated from the salivary glands of ticks or made by recombinant methods using various DNA expression techniques.
REFERENCES:
Cole et al. Science 1992; 258: 1650-54.
Valenzuela e tal. JBC. Jun. 2000; 275:18717-23.
Abendschein D.R. et al. 1995Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor. Circulation92(4):944-9.
Altschul S.F. et al. 1997Gapped Blast and PSI-Blast: a new generation of protein database search programs. Nucl Acids Res.25:3389-3402.
Anderson P.J. et al. 2000Characterization of proexosite I on prothrombin. J Biol Chem.275:16428-16434.
Bajaj M.S. & Bajaj S.P. 1997Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost.78:471-477.
Baugh R.J. et al. 2000Exosite interactions determine the affinity of FX for the extrinsic Xase complex. J Biol Chem.275:28826-28833.
Belaaouaj A. et al. 1993Revised cDNA sequence of rabbit tissue factor pathway inhibitor. Thromb Res.69(6):547-53.
Belaaouaj A. et al. 1993 Database accession No. S61902 Database GenBank Aug. 25.
Bergun P.W. et al. 2001Role of zymogen and activated FX as scaffolds for the inhibition of the blood coagulation FVIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J Biol Chem.276:10063-10071.
Bromberg M.E. & Cappello M. 1999Cancer and blood coagulation: molecular aspects. Cancer J Sci Am.5(3):132-8.
Broze G.J. Jr. et al. 1995Regulation of coagulation by multivalent Kunitz-type inhibitor. Biochemistry.29:7539-7546.
Broze G.J. Jr. et al. 1988The lipoprotein-associated coagulation inhibitor that inhibits the FVII-tissue factor complex also inhibits FXa: insight into its possible mechanism of action. Blood.71:335-343.
Broze, G.J. Jr.Tissue factor pathway inhbitor.In: Loscalzo J. & Schafer A.I. eds.Thrombosis and Hemorrhage. 2nd ed. Baltimore, MD: Williams & Wilkins; 1998:77-104.
Broze G.J. & Miletich J.P. 1987Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.PNAS USA. 84:1886-1890.
Davie E.W. et al. 1991The coagulation cascade: initiation, maintenance, and regulation. Biochemistry. 30:10363-10370.
Demchenko A.P. 2001Recognition between flexible protein molecules: induced and assisted folding. J Mol Recognit.14:42-61.
Dickinson C.D. et al. 1996Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease FVIIa. PNAS USA93:14379-14384.
Francischetti I.M. et al. 2001 Database accession No. AF286029 Database EMBL Aug. 2.
Francischetti I.M. et al. 2002Ixolaris, a novel recombinant tissue factor pathway inhibitor(TFPI)from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood.99(10):3602-12.
Francischetti I.M. et al. 1999Anophelin: kinetics and mechanism of thrombin inhibition. Biochemistry.38:16674-16685.
Girard T.J. et al. 1990Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science.248:1421-1424.
Girard T.J. et al. 1989Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature.338:518-520.
Hamamoto T. et al. 1993Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor(TFPI).J Biol Chem.268:8704-8710.
Han X. et al. 1999Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Arterioscler Thromb Vasc Biol.19:2563-2567.
Harker L.A. et al. 1996Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis.26:76-82.
Himber J. et al. 1997Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function. Thromb Haemost.78:1142-1149.
Ho G. et al. 2000Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo. Blood95:1973-1978.
Huang Z-F. et al. 1993Kinetics of FXa inhibition by tissue factor pathway inhibitor. J Biol Chem.268:26950-26955.
Huber R. et al. 1974Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor, II: crystallographic refinement at 1.9 A resolution. J Mol Biol.89:73-101.
Husten E.J. et al. 1987The active site of blood coagulation FXa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem.262:12953-12961.
Jenny N.S. & Mann K.G. 1998Coagulation cascade: an overview.In: Loscalzo J. & Schafer A.I. eds.Thrombosis and Hemorrhage.2nd ed. Baltimore, MD: Williams & Wilkins; 1998:3-27.
Jeske W. et al. 1996Pharmacological profiling of recombinant tissue factor pathway inhibitor. Semin Thromb Hemost.22:213-219.
Jonge E. et al. 1999Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood.95:1124-1129.
Karczewski J. et al. 1994Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata. J Biol Chem.269:6702-6708.
Kirchhofer D. et al. 2001The tissue factor region that interacts with FXa in the activation of FVII. Biochemistry.40:675-682.
Kirchhofer D. et al. 2000The tissue factor region that interacts with substrates FIX and FX. Biochemistry.3:7380-7387.
Komiyama Y. et al. 1991Proteolytic activation of human factors IX and X by recombinant human FVIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry.29:9418-9425.
Krishnaswamy S. & Betz A. 1997Exosites determine macromolecular substrate recognition by prothrombinase. Biochemistry36:12080-12086.
Lapatto R., et al. 1997X-ray structure of antistasin at 1.9 A resolution and its modeled complex with blood coagulation FXa. EMBO J.16:5151-5161.
Law L.H. et al. 1992Biochemical insights derived from insect diversity. Annu Rev Biochem.61:87-111.
Lee A. et al. 2001A dose-response study of recombinant FVIIa/TF inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation.104:74-78.
Lee G.F. et al. 1997Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins. Biochemistry.36:5608-5611.
Lindhout T. et al. 1995Kinetics of the inhibition of tissue factor-FVIIa by tissue factor pathway inhibitor. Thromb Haemost.74:910-915.
Locht A. et al. 1996The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J.15:6011-6017.
Markwardt F. 1999Inhibitors of Factor Xa from Haematophagous Animals Ann Haematol78(suppl 1): A4.
Nielsen H. et al. 1997A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng.10:1-6.
Orthner C. et al. 1995Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kB in TF induction by diverse agonists. Blood.86:436-443.
Pedersen A.H. et al. 1990Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J Biol Chem.254:16786-16793.
Petersen L.C. et al. 1996Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem.235:310-316.
Rao L.V.M. & Rapaport S.I. 1987Studies of a mechanism inhibiting the intiation of the extrinsic pathway of coagulation. Blood.69:645-651.
Rao L.V.M. & Ruf W. 1995Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor-VIIa with Xa-tissue factor pathway inhibitor. Biochemistry.34:10867-10871.
Rapaport S.I. 1989Inhibition of FVIIa/tissue factor-induced blood coagulation: with particular emphasis upon a FXa-dependent inhibitory mechanism. Blood.73:359-3
Francischetti Ivo M. B.
Ribeiro José M. C.
Valenzuela Jesus G.
Akhavan Ramin (Ray)
Guzo David
Knobbe Martens Olson & Bear LLP
The United States of America as represented by the Department of
LandOfFree
Ixodes scapularis tissue factor pathway inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ixodes scapularis tissue factor pathway inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ixodes scapularis tissue factor pathway inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3550100